Ranbaxy and PC Pharma unveil new facility investments, Ethypharm will manufacture Ampio drug, DPT Labs is warned by the FDA …
Recruitment drive starts at Aesica, Affymax names a new manufacturing head, plus updates from NeoStem, DPT Labs and HAL Allergy.
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact

